150 related articles for article (PubMed ID: 15619245)
1. Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference.
Gerbes AL; Gülberg V
Hepatology; 2005 Jan; 41(1):217. PubMed ID: 15619245
[No Abstract] [Full Text] [Related]
2. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
Albillos A; Bañares R; González M; Catalina MV; Molinero LM
J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
[TBL] [Abstract][Full Text] [Related]
3. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
Bureau C; Métivier S; D'Amico M; Péron JM; Otal P; Pagan JC; Chabbert V; Chagneau-Derrode C; Procopet B; Rousseau H; Bosch J; Vinel JP
J Hepatol; 2011 May; 54(5):901-7. PubMed ID: 21145798
[TBL] [Abstract][Full Text] [Related]
4. TIPS versus paracentesis for the treatment of refractory ascites.
Lau A; Bay C; Nadir A
Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
[No Abstract] [Full Text] [Related]
5. Cirrhosis with refractory ascites: serial large volume paracentesis, TIPS, or transplantation?
Khungar V; Saab S
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):931-5; quiz e121-2. PubMed ID: 21627999
[No Abstract] [Full Text] [Related]
6. Pros and cons of TIPS for refractory ascites.
Sanyal AJ
J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
[No Abstract] [Full Text] [Related]
7. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
8. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
Aalykke C; Tønner-Nielsen D; Vilstrup H
Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
[No Abstract] [Full Text] [Related]
9. Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts.
Gülberg V; Liss I; Bilzer M; Waggershauser T; Reiser M; Gerbes AL
Digestion; 2002; 66(2):127-30. PubMed ID: 12428073
[TBL] [Abstract][Full Text] [Related]
10. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
11. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
12. Dynamic MR perfusion measurements before and after TIPS in cirrhotic patients with refractory ascites.
Maleux G; De Keyzer F; Prinsloo J; Heye S; Nevens F; Marchal G
Acad Radiol; 2007 Nov; 14(11):1400-8. PubMed ID: 17964463
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic porto-systemic shunt to relieve refractory ascites in a patient with cirrhosis and portal hypertension.
Joseph G; George OK; Jayanthi V
Indian Heart J; 2002; 54(6):731-2. PubMed ID: 12674194
[No Abstract] [Full Text] [Related]
14. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
15. [TIPS: value in the treatment of therapy refractory ascites].
Staritz M; Jaeger O; Matschke H; Riesterer H; Sauer B
Z Gastroenterol; 2000 Aug; 38(8):655-6. PubMed ID: 11031792
[No Abstract] [Full Text] [Related]
16. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
17. [Chylous ascites and TIPS].
Vargas L; Lobo S; Agar S; Rodríguez A; Soto JR
Rev Med Chil; 1997 Feb; 125(2):220-1. PubMed ID: 9430944
[No Abstract] [Full Text] [Related]
18. Torulopsis glabrata fungemia from infected transjugular intrahepatic portosystemic shunt stent.
Brickey TW; Trotter JF; Johnson SP
J Vasc Interv Radiol; 2005 May; 16(5):751-2. PubMed ID: 15872333
[TBL] [Abstract][Full Text] [Related]
19. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
Kavitt RT; Yang VL; Jensen DM
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
[TBL] [Abstract][Full Text] [Related]
20. Incarcerated umbilical hernia after transjugular intrahepatic portosystemic shunt procedure for refractory ascites.
Mallavarapu RK; Grimsley EW
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):A26. PubMed ID: 17825762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
